Invest now
Innova Captab share price
Balanced risk
- ₹968.30(-4.23%)July 17, 2026 15:28:38 PM IST
- NSE
- BSE
- Vol : 60.41 K (NSE + BSE)Last 20 day avg : 56.22 K
Innova Captab is trading -4.23% lower at Rs 968.30 as compared to its last closing price. Innova Captab has been trading in the price range of 1,004.50 & 959.95. Innova Captab has given 40.44% in this year & 2.06% in the last 5 days. Innova Captab has TTM P/E ratio 28.01 as compared to the sector P/E of 42.13.There are 2 analysts who have initiated coverage on Innova Captab. There are 0.00 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 38.08 Crores in its last quarter.Listed peers of Innova Captab include Sun Pharmaceutical Industries (-0.87%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (-4.50%).The Mutual Fund holding in Innova Captab was at 9.18% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Innova Captab was at 0.34% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 18 Jul 2026, 04:50 PM IST
- Debt To EquityHigher than industry0.32The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.20Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation2.03The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Innova Captab News
Innova Captab Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,933.10 | -0.87 | 4,63,804.52 | 38.74 | 5.6 | - | - |
| Divi's Laboratories | 7,258.05 | -0.84 | 1,92,678.42 | 74.01 | 11.59 | - | - |
| Torrent Pharmaceuticals | 4,763.00 | -4.50 | 1,61,251.85 | 76.16 | 20.12 | - | - |
| Cipla | 1,418.40 | -0.77 | 1,14,551.98 | 27.78 | 3.35 | - | - |
| Zydus Lifesciences | 1,142.75 | -0.93 | 1,13,894.32 | 21.38 | 4.28 | - | - |
Mutual Fund Ownership
View allInnova Captab Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-07 | Audited Results |
| 2026-01-23 | Quarterly Results, Dividend & Others |
| 2025-11-07 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-19 | Audited Results |
About the company Innova Captab
- IndustryBiotechnology & Drugs
- ISININE0DUT01020
- BSE Code544067
- NSE CodeINNOVACAP
Innova Captab Limited is an India-based integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes Contract Development and Manufacturing (CDMO) Services and Products, Domestic Branded Generics, and International Branded Generics. Its CDMO business provides research, product development and manufacturing services. Its Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including tablets, capsules, dry syrups, and others.
Innova Captab Share Price FAQs
Innova Captab is trading at 968.30 as on Fri Jul 17 2026 09:58:38. This is -4.23% lower as compared to its previous closing price of 1011.05.
The market capitalization of Innova Captab is 5512.76 Cr as on Fri Jul 17 2026 09:58:38.
The average broker rating on Innova Captab is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Innova Captab is 1033.00 whereas the 52 wk low is 608.25
Innova Captab can be analyzed on the following key metrics -
- TTM P/E: 28.01
- Sector P/E: 42.13
- Dividend Yield: 0.20%
- D/E ratio: 0.32
Innova Captab reported a net profit of 140.92 Cr in 2026.
The Mutual Fund Shareholding was 9.18% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Innova Captab QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.